What will European Parliament elections mean for CBD?

Written by CBD-Intel || 23rd May 2019 || Regulatory briefing |

Europe

Policy and Politics

Regulation and Legislation

Regulatory briefing

Many parties taking part in the current European parliamentary elections would like to see more research on the effects of CBD before passing pro-CBD legislation ...

UK medical bodies leave CBD out of their discussions on cannabis

Written by CBD-Intel || 21st May 2019 || Business briefing |

Europe

United Kingdom

Public Health and Medicine

Business briefing

More and more British organisations are starting to develop a policy towards medical cannabis, but CBD guidelines appear to be lagging behind ...

CBD and cannabis news in brief: United States

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Colorado

Florida

Indiana

Maine

New Jersey

New York

North America

North Dakota

Tennessee

United States

Regulation and Legislation

Regulatory briefing

The first in a new weekly round-up from around the US brings you news from Colorado, Florida, Indiana, Maine, New Jersey, New York, North Dakota, and Tennessee ...

CBD and cannabis news in brief: International

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Asia

Canada

India

North America

World

Companies

Marketing and Retailing

Policy and Politics

Regulation and Legislation

Regulatory briefing

The first in a new weekly round-up from around the world brings you news from India, Canada – and the International Space Station ...

CBD and cannabis news in brief: Europe

Written by CBD-Intel || 20th May 2019 || Regulatory briefing |

Belgium

Czech Republic

EU

Europe

Germany

Lithuania

Netherlands

Switzerland

Policy and Politics

Regulation and Legislation

Regulatory briefing

The first in a new weekly round-up from around Europe brings you news from Belgium, Germany, Switzerland, the Netherlands, the Czech Republic, Lithuania and the EU ...

Government funding puts wind in the sails of Irish CBD companies

Written by CBD-Intel || 16th May 2019 || Business briefing |

Europe

Ireland

Companies

Policy and Politics

Business briefing

Funding is available for Irish CBD businesses from Enterprise Ireland, a government body facilitating business development ...

Salvini’s bid to close down Italy’s CBD trade appears to be an empty threat

Written by CBD-Intel || 16th May 2019 || Regulatory briefing |

Europe

Italy

Marketing and Retailing

Policy and Politics

Regulation and Legislation

Regulatory briefing

The Italian CBD market should not be severely curtailed despite deputy prime minister Matteo Salvini’s threat to destroy the legal cannabis industry ...

Japan’s new CBD stores tread softly but promise big things to come

Written by CBD-Intel || 14th May 2019 || Business briefing |

Asia

Japan

Companies

Marketing and Retailing

Business briefing

The nascent CBD sector in Japan gained a new outlet when the H&F Dispensary opened at the beginning of May in Hiroshima ...

Some fear extracts ban as Germany beefs up constraints on CBD sales

Written by CBD-Intel || 14th May 2019 || Regulatory briefing |

EU

Europe

Germany

Companies

Regulation and Legislation

Regulatory briefing

Germany is tightening controls on CBD sales in a move that may lead to a ban on hemp extracts in Europe’s largest market and which has led some chain stores to remove products from shelves ...

Israeli and Chinese companies come to an understanding on cannabis

Written by CBD-Intel || 13th May 2019 || Business briefing |

Asia

China

Israel

Companies

Regulation and Legislation

Business briefing

A new partnership expands Israel’s global cannabis ties and gives a Chinese investor access to an entire portfolio of cannabis and hemp-related start-ups ...

Belgium makes smokable flower rules clear – but tax plan raises fears

Written by CBD-Intel || 13th May 2019 || Regulatory briefing |

Belgium

EU

Europe

Regulation and Legislation

Regulatory briefing

Regulations on the sale of smokable CBD flower products in Belgium have been clarified. But taxing the products like tobacco could send users to the black market, a campaign group has warned ...

CBD stakeholders join the parade at grand Paris cannabis festival

Written by CBD-Intel || 8th May 2019 || Business briefing |

Europe

France

Companies

Marketing and Retailing

Regulation and Legislation

Business briefing

Participants at the Paris 420 Festival, organised by NORML France (National Organisation for the Reform of Marijuana Laws), were keen to raise public awareness of hemp’s various properties ...

US veterans at odds with federal agency over legalising clinical trials

Written by CBD-Intel || 8th May 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Public Health and Medicine

Regulatory briefing

The US Department of Veterans Affairs has opposed three CBD-related bills in Congress, leading some to wonder if the agency is looking to punish veterans who admit using medical cannabis ...

Sports supplement chain puts CBD products into malls across US

Written by CBD-Intel || 6th May 2019 || Business briefing |

North America

United States

Companies

Marketing and Retailing

Business briefing

A major sports supplement chain is the latest business to bring CBD to its shelves in the US ...

Willie Nelson expands; high finance; ‘high’ burger; biosynthetic CBD

Written by CBD-Intel || 1st May 2019 || Business briefing |

Canada

North America

United Kingdom

United States

Companies

Marketing and Retailing

Technology and Innovation

Business briefing

CBD-Intel News in Brief from the US, Canada and UK ...

Mile High sets up UK operations in Belfast, with London opening next

Written by CBD-Intel || 30th April 2019 || Business briefing |

England

EU

Europe

Northern Ireland

United Kingdom

Companies

Business briefing

One of the largest CBD companies in the US has opened up a UK base in Northern Ireland, and is on the brink of setting up another in London ...

Will FDA draw a line between other CBD products and pharmaceuticals?

Written by CBD-Intel || 29th April 2019 || Regulatory briefing |

North America

United States

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The US FDA is to hold a public hearing on 31st May on the safety of products containing cannabis or cannabis-derived compounds ― and stakeholders will be looking for a dividing line ...

When will CBD foods be legal in the US? Don’t hold your breath

Written by CBD-Intel || 25th April 2019 || Regulatory briefing |

North America

United States

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Could CBD soon be legally sold as a dietary supplement or food in the US? The answer depends on how quickly the federal regulatory framework on cannabis in general and CBD in particular can be eased ...

Hemp growing on the rise, but Ireland still sends abroad for medical supplies

Written by CBD-Intel || 25th April 2019 || Regulatory briefing |

Europe

Ireland

Companies

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Ireland’s Department of Health still won’t commit to allowing farmers to grow cannabis for medical use, two years after the health minister announced a medical cannabis access programme ...

Child health association ‘an obstacle to cannabis prescriptions,’ claims UK MP

Written by CBD-Intel || 24th April 2019 || Regulatory briefing |

United Kingdom

Policy and Politics

Public Health and Medicine

Regulatory briefing

A UK member of parliament has accused the president of a child healthcare organisation of lying to the parliamentary health and social care committee and dismissing the concerns of families ...

Brits back CBD for health; hemp seeds can be imported in US; German raids

Written by CBD-Intel || 23rd April 2019 || Business briefing |

Europe

Germany

North America

United Kingdom

United States

Companies

Marketing and Retailing

Regulation and Legislation

Business briefing

CBD-Intel News in Brief from the UK, US and Germany ...

How social media influencers can make fame pay in the CBD market

Written by CBD-Intel || 22nd April 2019 || Business briefing |

Europe

North America

United Kingdom

United States

Companies

Marketing and Retailing

Business briefing

Social media influencers are the marketing medium of the moment, and the CBD market is especially well suited to cashing in on the fame and popularity of this new form of advertising ...

New regulation kick-starts CBD and cannabis industry in Peru

Written by CBD-Intel || 19th April 2019 || Business briefing |

Peru

South America

Companies

Regulation and Legislation

Business briefing

As a potential CBD and cannabis market emerges in Peru, players from across the globe are seeing a valuable opportunity for investing in the country ...

Mexican legalisation may come with added regulation and controls

Written by CBD-Intel || 18th April 2019 || Regulatory briefing |

Mexico

North America

Policy and Politics

Regulation and Legislation

Regulatory briefing

Mexico is well on its way to fully legalising cannabis and its derivative products, but the new government may impose stricter regulation than that left by the previous regime ...

Big Pharma ‘must not be allowed to set EU legal agenda on medical cannabis’

Written by CBD-Intel || 17th April 2019 || Regulatory briefing |

EU

Europe

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Europe desperately needs harmonised legislation on medical cannabis – but it could take five years, and Big Pharma must not be allowed to set the agenda, delegates at a conference in Brussels heard ...

Social difficulties – how the big networks get in a tangle over CBD

Written by CBD-Intel || 15th April 2019 || Business briefing |

Europe

North America

United Kingdom

United States

Companies

Marketing and Retailing

Business briefing

CBD’s association with cannabis, on one level part of its marketing strength, can also be a big barrier to its acceptance. The major social networks all have as yet a rather ambiguous attitude ...

Swedish firms rein in dietary sales and health claims until courts decide

Written by CBD-Intel || 9th April 2019 || Business briefing |

Europe

Sweden

Companies

Marketing and Retailing

Regulation and Legislation

Business briefing

Several Swedish companies offering dietary supplements with CBD oil produced from industrial hemp have either stopped selling the products or significantly toned down promises of its health benefits ...

Questions in UK parliament after medical cannabis is seized at airport

Written by CBD-Intel || 9th April 2019 || Regulatory briefing |

Europe

United Kingdom

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Just two out of around 80 people prescribed medical cannabis in the UK have received products containing THC, with the rest getting CBD, the British parliament has heard ...

Federal assistance proposed for US CBD businesses with banking issues

Written by CBD-Intel || 5th April 2019 || Regulatory briefing |

North America

United States

Regulation and Legislation

Regulatory briefing

Proposed new federal legislation in the US could finally help CBD businesses gain easier access to banking, a problem that has bedevilled legal cannabis-related industries since their...

EU agriculture committee approves proposal to raise THC limit to 0.3%

Written by CBD-Intel || 3rd April 2019 || Regulatory briefing |

EU

Europe

Regulation and Legislation

Regulatory briefing

The European Parliament’s agriculture committee has approved proposals to put forward an amendment to the Common Agriculture Policy allowing hemp farmers to grow varieties with as much as 0.3% THC ...

Mile High accuses rival CBD firm of copyright infringement and deceit

Written by CBD-Intel || 1st April 2019 || Business briefing |

North America

United States

Companies

Regulation and Legislation

Technology and Innovation

Business briefing

Investments made by Turning Point Brands in a CBD extraction company were based on misleading information, a lawsuit filed in a US court alleges ...

Cannabis troubles – UK committee hears of inconsistency and confusion

Written by CBD-Intel || 26th March 2019 || Regulatory briefing |

United Kingdom

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

Inconsistent quality of products purchased online, and confusion over cannabis itself, could be putting patients at risk, a group of UK MPs were told during presentations on medical cannabis and related issues ...

Cannabis is popular left, right and centre as Israeli election approaches

Written by CBD-Intel || 22nd March 2019 || Regulatory briefing |

Asia

Israel

Policy and Politics

Regulation and Legislation

Regulatory briefing

Politicians in Israel are rarely united on any single issue, but as the much contended Israeli election draws nearer, members from across the political spectrum support the full legalisation of recreational cannabis ...

All time high in sales for CBD’s new player Turning Point Brands

Written by CBD-Intel || 21st March 2019 || Business briefing |

Kentucky

North America

United States

Companies

Business briefing

An e-cig company that has recently entered the CBD arena has reported record increases in sales and profit...

Europe’s biggest extraction plant opens in Sicily with Canadian backing

Written by CBD-Intel || 19th March 2019 || Business briefing |

Europe

Italy

Companies

Technology and Innovation

Business briefing

A new hemp extraction facility, said to be the largest in Europe, has opened in the Sicilian province of Ragusa for the production of CBD-containing products such as oils, cosmetics, and pharmaceuticals ...

There’s room yet for growth and untangling in Canada’s legal reform

Written by CBD-Intel || 18th March 2019 || Regulatory briefing |

Canada

North America

Companies

Policy and Politics

Regulation and Legislation

Regulatory briefing

Nearly five months after Canada legalised cannabis, its fledgling system for delivering cannabis and CBD products to consumers is still experiencing growing pains ...

Jelly bean king Klein is hoping for the sweet smell of CBD success

Written by CBD-Intel || 13th March 2019 || Business briefing |

North America

United States

Companies

Marketing and Retailing

Business briefing

David Klein, the man who created the iconic Jelly Belly jelly bean in the 1970s, has entered the CBD edibles market with his latest start-up Spectrum Confections, established to make CBD jelly beans ...

Status and future of CBD oil in Sweden is in the lap of the courts

Written by CBD-Intel || 12th March 2019 || Regulatory briefing |

EU

Europe

Sweden

Regulation and Legislation

Regulatory briefing

The future of CBD oil in Sweden is about to be decided as several cases inch their way through the country’s administrative courts ...

Big dollars are undeterred by red tape tangle and inconsistent enforcement

Written by CBD-Intel || 11th March 2019 || Business briefing |

Canada

North America

United States

Companies

Marketing and Retailing

Public Health and Medicine

Business briefing

North American businesses are still investing millions in the CBD hemp market, despite the uncertainty generated by new legislation and clampdowns on retailers, with many US and Canadian firms acquiring nascent businesses ...

CBD to treat concussion disorders? Retired NHL players join study

Written by CBD-Intel || 8th March 2019 || Business briefing |

Canada

North America

United States

Companies

Public Health and Medicine

Technology and Innovation

Business briefing

A charity for retired ice hockey players is teaming up with one of the world’s biggest cannabis companies and a medical research body to research how CBD treatment impacts concussion-related disorders ...

French CBD users warned against buying from illicit online suppliers

Written by CBD-Intel || 7th March 2019 || Regulatory briefing |

EU

Europe

France

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The French Medicines Agency (Agence Nationale du Médicament, ANSM) has issued a warning to consumers against buying illicit CBD products online ...

FDA jurisdiction still unchallenged – but industry presses for clarity

Written by CBD-Intel || 1st March 2019 || Regulatory briefing |

North America

United States

Policy and Politics

Regulation and Legislation

Regulatory briefing

The US Food and Drug Administration is moving slowly in drawing regulatory boundaries for CBD businesses. Members of Congress have called for clarity, but the FDA says it has no plans to give cannabis derivatives the green light...

FDA sets the date for hearing on legalising hemp-derived CBD

Written by CBD-Intel || 1st March 2019 || Regulatory briefing |

California

Maine

North America

United States

Wisconsin

Policy and Politics

Public Health and Medicine

Regulation and Legislation

Regulatory briefing

The US Food and Drug Administration (FDA) has set a tentative date of sometime in April for a long-awaited public meeting to hear from stakeholders and begin a rulemaking process on legalising hemp-derived CBD, according to FDA Commissioner...

Swiss report signals ‘the beginning of the end of cannabis prohibition’

Written by CBD-Intel || 28th February 2019 || Regulatory briefing |

Europe

Switzerland

Policy and Politics

Regulation and Legislation

Regulatory briefing

Growing acceptance and use of CBD in Switzerland, as demonstrated in a recent report, could eventually lead to legalisation of cannabis in the country, according to a range of experts ...

First cases of CBD shops allowed to reopen, but France remains confused

Written by CBD-Intel || 27th February 2019 || Regulatory briefing |

EU

Europe

France

Regulation and Legislation

Regulatory briefing

The French CBD market looks more promising as shops shut down last year through legal action have begun to re-open – though elsewhere in the country others are still being closed and their owners prosecuted ...

Deal signals plans for ‘sustainable’ bio-synthesised CBD

Written by CBD-Intel || 26th February 2019 || Business briefing |

North America

United States

Companies

Business briefing

The commercialisation of bio-synthesised cannabidiol could be on the horizon following the announcement by Amyris that it will be forming a new partnership to focus on “cannabinoid development”. The California-based company is best known for creating synthetic sweeteners...

CBD foods can’t be made in Italy, health ministry confirms

Written by CBD-Intel || 18th February 2019 || Regulatory briefing |

EU

Europe

Italy

Regulation and Legislation

Regulatory briefing

The production of foods containing cannabinoids is not permitted in Italy, the country’s health ministry has confirmed to CBD-Intel ...

Europe votes for medical cannabis – in theory and on certain conditions

Written by CBD-Intel || 14th February 2019 || Regulatory briefing |

EU

Europe

Policy and Politics

Regulation and Legislation

Regulatory briefing

The European Parliament has passed a resolution supporting medical cannabis – though only in cases where a product has gone through clinical trials and a regulatory approval process ...

Cannabis companies team up with pharma firm to supply Europe

Written by CBD-Intel || 14th February 2019 || Business briefing |

Canada

Europe

Greece

North America

Poland

United States

Companies

Business briefing

Two of the largest legal cannabis companies, Wayland and International Cannabis Corp, are teaming up with a multinational pharmaceutical organisation in a bid to create significant amounts of CBD for the European market ...

It’s a smoking hot issue – Swiss CBD users like flowers best

Written by CBD-Intel || 13th February 2019 || Business briefing |

Europe

Switzerland

Market Research

Marketing and Retailing

Business briefing

Swiss consumers use CBD for assorted reasons, but one thing is clear: most prefer to smoke it. A preference for flowers was one major finding of a study into the habits of CBD users in Switzerland ...